142 related articles for article (PubMed ID: 8557519)
21. Antilymphocytic activity of erythromycin distinct from that of FK506 or cyclosporin A.
Keicho N; Kudoh S; Yotsumoto H; Akagawa KS
J Antibiot (Tokyo); 1993 Sep; 46(9):1406-13. PubMed ID: 7693639
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of activation-induced changes in the structure of the T cell interleukin-7 receptor by cyclosporin A and FK506.
Foxwell BM; Willcocks JL; Taylor-Fishwick DA; Kulig K; Ryffel B; Londei M
Eur J Immunol; 1993 Jan; 23(1):85-9. PubMed ID: 7678231
[TBL] [Abstract][Full Text] [Related]
23. Sensitivity of whole-blood T lymphocytes in individual patients to tacrolimus (FK 506): impact of interleukin-2 mRNA expression as surrogate measure of immunosuppressive effect.
Härtel C; Schumacher N; Fricke L; Ebel B; Kirchner H; Müller-Steinhardt M
Clin Chem; 2004 Jan; 50(1):141-51. PubMed ID: 14709642
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of human T-cell activation by FK 506, rapamycin, and cyclosporine A.
Sigal NH; Lin CS; Siekierka JJ
Transplant Proc; 1991 Apr; 23(2 Suppl 2):1-5. PubMed ID: 1712132
[No Abstract] [Full Text] [Related]
25. Mechanism of calcium ionophore and phorbol ester-induced T-cell activation. Accessory cell requirement for T-cell activation.
Hashimoto S; Takahashi Y; Tomita Y; Hayama T; Sawada S; Horie T; McCombs CC; Michalski JP
Scand J Immunol; 1991 Apr; 33(4):393-403. PubMed ID: 2017664
[TBL] [Abstract][Full Text] [Related]
26. Anti-CD3 antibody-induced expression of both p55 and p75 chains of the high affinity interleukin-2 receptor on human T lymphocytes is inhibited by cyclosporin A.
Foxwell BM; Simon J; Herrero JJ; Taylor D; Woerly G; Cantrell D; Ryffel B
Immunology; 1990 Jan; 69(1):104-9. PubMed ID: 2312149
[TBL] [Abstract][Full Text] [Related]
27. Effect of FK506 on the interleukin 15-driven proliferation and apoptosis of anti-CD3-activated umbilical cord blood T cells.
Lin SJ; Yan DC; Kuo ML; Cheng PJ; Hsiao SS; Tsai TL
Ann Allergy Asthma Immunol; 2005 Dec; 95(6):586-92. PubMed ID: 16400900
[TBL] [Abstract][Full Text] [Related]
28. A purified protein from Salmonella typhimurium inhibits proliferation of murine splenic anti-CD3 antibody-activated T-lymphocytes.
Matsui K
FEMS Immunol Med Microbiol; 1996 Jun; 14(2-3):121-7. PubMed ID: 8809547
[TBL] [Abstract][Full Text] [Related]
29. Human T cell responses to human and porcine endothelial cells are highly sensitive to cyclosporin A and FK506 in vitro.
Batten P; McCormack AM; Page CS; Yacoub MH; Rose ML
Transplantation; 1999 Nov; 68(10):1552-60. PubMed ID: 10589954
[TBL] [Abstract][Full Text] [Related]
30. Cyclosporin A inhibits induction of IL-2 receptor alpha chain expression by affecting activation of NF-kB-like factor(s) in cultured human T lymphocytes.
Brini AT; Harel-Bellan A; Farrar WL
Eur Cytokine Netw; 1990; 1(3):131-9. PubMed ID: 2129797
[TBL] [Abstract][Full Text] [Related]
31. Activation of human T lymphocytes by phorbol-12,13-dibutyrate and ionomycin.
Larsen CS
Scand J Immunol; 1990 Mar; 31(3):353-60. PubMed ID: 2320954
[TBL] [Abstract][Full Text] [Related]
32. Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome.
Zhang Q; Nowak I; Vonderheid EC; Rook AH; Kadin ME; Nowell PC; Shaw LM; Wasik MA
Proc Natl Acad Sci U S A; 1996 Aug; 93(17):9148-53. PubMed ID: 8799169
[TBL] [Abstract][Full Text] [Related]
33. Tepoxalin, a novel immunosuppressive agent with a different mechanism of action from cyclosporin A.
Zhou L; Ritchie D; Wang EY; Barbone AG; Argentieri D; Lau CY
J Immunol; 1994 Dec; 153(11):5026-37. PubMed ID: 7963563
[TBL] [Abstract][Full Text] [Related]
34. Activation of transcription factor NF kappa B in Jurkat cells is inhibited selectively by FK 506 in a signal-dependent manner.
Su MS; Semerjian A
Transplant Proc; 1991 Dec; 23(6):2912-5. PubMed ID: 1721310
[No Abstract] [Full Text] [Related]
35. The effect of the CD28 activation pathway on the immunosuppressive action of cyclosporine.
Hess AD; Bright EC
Transplantation; 1991 Jun; 51(6):1232-40. PubMed ID: 1646506
[TBL] [Abstract][Full Text] [Related]
36. Cyclosporin A inhibits T cell receptor-induced interleukin-2 synthesis of human T lymphocytes by selectively preventing a transmembrane signal transduction pathway leading to sustained activation of a protein kinase C isoenzyme, protein kinase C-beta.
Szamel M; Bartels F; Resch K
Eur J Immunol; 1993 Dec; 23(12):3072-81. PubMed ID: 8258320
[TBL] [Abstract][Full Text] [Related]
37. Effect of cyclosporin A, FK506 and rapamycin on proliferation and soluble IL-2 receptor release from mitogenically stimulated rat spleen cells.
Pockley AG; Williams S; Reid SD; Bowles MJ
Biochem Soc Trans; 1995 Nov; 23(4):615S. PubMed ID: 8654800
[No Abstract] [Full Text] [Related]
38. FK506 and rapamycin selectively enhance degradation of IL-2 and GM-CSF mRNA.
Hanke JH; Nichols LN; Coon ME
Lymphokine Cytokine Res; 1992 Oct; 11(5):221-31. PubMed ID: 1281674
[TBL] [Abstract][Full Text] [Related]
39. IL-2-dependent induction of G1 cyclins in primary T cells is not blocked by rapamycin or cyclosporin A.
Turner JM
Int Immunol; 1993 Oct; 5(10):1199-209. PubMed ID: 8268127
[TBL] [Abstract][Full Text] [Related]
40. Differences in the induction of induced human CD4(+) CD25(+) FoxP3(+) T-regulatory cells and CD3(+) CD8(+) CD28(-) T-suppressor cells subset phenotypes in vitro: comparison of phorbol 12-myristate 13-acetate/ionomycin and phytohemagglutinin stimulation.
Wang H; Daniel V; Sadeghi M; Opelz G
Transplant Proc; 2013 Jun; 45(5):1822-31. PubMed ID: 23769052
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
